Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/15/01 → 5/15/04 |
A Phase III, Multi-National, Multi-Site, Double-Blind, Placebo-Controlled, 28 Week Study to Assess the Safety & Efficacy of the Engineered Human Anti-TNFa Antibody, CDP571 (10mg/kg), in Patient With Active Crohn's Disease
- De Villiers, Willem (PI)